METHODOLOGY OF RENAL SCINTIGRAPHY WITH ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR

被引：0
|
作者：
BAULIEU, F
RAMACKERS, JM
MURE, A
COSCULLELA, S
JEANDOT, R
PERDRISOT, R
BAULIEU, JL
LECLOIREC, J
机构：
[1] CHU TOURS,SERV MED NUCL IN VIVO & ULTRASONS,F-37044 TOURS,FRANCE
[2] SERV EXPLORAT ISOTOP,F-69473 LYON,FRANCE
[3] HOP ST ANTOINE,NUCL MED SERV,F-75571 PARIS,FRANCE
[4] CHU PELLEGRIN,NUCL MED SERV,F-33076 BORDEAUX,FRANCE
[5] CHU LIMOGES,NUCL MED SERV,F-87042 LIMOGES,FRANCE
[6] CTR EUGENE MARQUIS,NUCL MED SERV,F-35062 RENNES,FRANCE
来源：
MEDECINE NUCLEAIRE | 1995年 / 19卷 / 5-6期
关键词：
ANGIOTENSIN CONVERTING ENZYME INHIBITOR; CAPTOPRIL; ARTERIAL HYPERTENSION; RENOVASCULAR HYPERTENSION; KIDNEY; METHODOLOGY;
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
This methodological paper is based upon the data in the literature concerning the renal scintigraphy following angiotensin converting enzyme inhibition in the diagnosis of renovascular hypertension. After briefly recalling the pathophysiological considerations necessary for understanding the test, we reviewed the current knowledge about the handling of different radiopharmaceutical agents, the patient preparation, the radionuclide scan procedure, and finally examined proposed parameters for test interpretation.
引用
下载
收藏
页码：289 / 299
页数：11
相关论文
共 50 条
  • [1] ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR FETOPATHY
    PRYDE, PG
    SEDMAN, AB
    NUGENT, CE
    BARR, M
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1993, 3 (09): : 1575 - 1582
  • [2] CAPTOPRIL - ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR
    KOCH, H
    PHARMACY INTERNATIONAL, 1981, 2 (08): : 164 - 165
  • [3] ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR THERAPY
    OPIE, LH
    PRZYBOJEWSKI, JZ
    SOUTH AFRICAN MEDICAL JOURNAL, 1992, 81 (04): : 183 - 185
  • [4] LISINOPRIL - A NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR
    CHASE, SL
    SUTTON, JD
    PHARMACOTHERAPY, 1989, 9 (03): : 120 - 130
  • [5] LISINOPRIL - A NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR
    ARMAYOR, GM
    LOPEZ, LM
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1988, 22 (05): : 365 - 372
  • [6] CONSEQUENCES OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR OVERDOSE
    VARUGHESE, A
    TAYLOR, AA
    NELSON, EB
    AMERICAN JOURNAL OF HYPERTENSION, 1989, 2 (05) : 355 - 357
  • [7] LISINOPRIL - A NONSULFHYDRYL ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR
    NOBLE, TA
    MURRAY, KM
    CLINICAL PHARMACY, 1988, 7 (09): : 659 - 669
  • [8] ENALAPRIL, A NONSULFHYDRYL ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR
    VLASSES, PH
    LARIJANI, GE
    CONNER, DP
    FERGUSON, RK
    CLINICAL PHARMACY, 1985, 4 (01): : 27 - 40
  • [9] ENALAPRIL - A NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR
    WEINTRAUB, M
    EVANS, P
    HOSPITAL FORMULARY, 1985, 20 (07): : 796 - &
  • [10] ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR IN THE TREATMENT OF ANGINA
    BUSSMANN, WD
    WITTIG, RA
    BRUNNER, I
    BAHRMANN, H
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1992, 117 (16) : 603 - 606
12345